Cargando…
Monitoring sertraline and clozapine levels
INTRODUCTION: One of the most frequent side effects seen when prescribing sertraline and clozapine together is the appearance of a seizure crisis. This event is usually related to an increase of plasmatic concentration due to interactions of these drugs with blood components. OBJECTIVES: To investig...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567760/ http://dx.doi.org/10.1192/j.eurpsy.2022.1852 |
_version_ | 1784809480806989824 |
---|---|
author | Rodriguez Campos, A. Rodriguez Andrés, L. Medina Ojeda, G. Santos Carrasco, I. Gonçalves Cerejeira, J. Gonzaga, A. |
author_facet | Rodriguez Campos, A. Rodriguez Andrés, L. Medina Ojeda, G. Santos Carrasco, I. Gonçalves Cerejeira, J. Gonzaga, A. |
author_sort | Rodriguez Campos, A. |
collection | PubMed |
description | INTRODUCTION: One of the most frequent side effects seen when prescribing sertraline and clozapine together is the appearance of a seizure crisis. This event is usually related to an increase of plasmatic concentration due to interactions of these drugs with blood components. OBJECTIVES: To investigate the effects of clozapine when combined with other drugs, especially its effects increasing plasmatic concentration. METHODS: A patient was treated sith 300 mg/day of clozapine followed by a treatment with sertraline 50 mg/day, which increases plasmatic concentration. The combination of these treatments produced seizures. Other works published about interactions are reviewed. RESULTS: It is important to monitor clozapine dosages to avoid increasing plasmatic concentration, especially if other drugs that have this effect are also administered. CONCLUSIONS: It is important to monitor clozapine dosages to avoid increasing plasmatic concentration, especially if other drugs that have this effect are also administered. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9567760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95677602022-10-17 Monitoring sertraline and clozapine levels Rodriguez Campos, A. Rodriguez Andrés, L. Medina Ojeda, G. Santos Carrasco, I. Gonçalves Cerejeira, J. Gonzaga, A. Eur Psychiatry Abstract INTRODUCTION: One of the most frequent side effects seen when prescribing sertraline and clozapine together is the appearance of a seizure crisis. This event is usually related to an increase of plasmatic concentration due to interactions of these drugs with blood components. OBJECTIVES: To investigate the effects of clozapine when combined with other drugs, especially its effects increasing plasmatic concentration. METHODS: A patient was treated sith 300 mg/day of clozapine followed by a treatment with sertraline 50 mg/day, which increases plasmatic concentration. The combination of these treatments produced seizures. Other works published about interactions are reviewed. RESULTS: It is important to monitor clozapine dosages to avoid increasing plasmatic concentration, especially if other drugs that have this effect are also administered. CONCLUSIONS: It is important to monitor clozapine dosages to avoid increasing plasmatic concentration, especially if other drugs that have this effect are also administered. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567760/ http://dx.doi.org/10.1192/j.eurpsy.2022.1852 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Rodriguez Campos, A. Rodriguez Andrés, L. Medina Ojeda, G. Santos Carrasco, I. Gonçalves Cerejeira, J. Gonzaga, A. Monitoring sertraline and clozapine levels |
title | Monitoring sertraline and clozapine levels |
title_full | Monitoring sertraline and clozapine levels |
title_fullStr | Monitoring sertraline and clozapine levels |
title_full_unstemmed | Monitoring sertraline and clozapine levels |
title_short | Monitoring sertraline and clozapine levels |
title_sort | monitoring sertraline and clozapine levels |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567760/ http://dx.doi.org/10.1192/j.eurpsy.2022.1852 |
work_keys_str_mv | AT rodriguezcamposa monitoringsertralineandclozapinelevels AT rodriguezandresl monitoringsertralineandclozapinelevels AT medinaojedag monitoringsertralineandclozapinelevels AT santoscarrascoi monitoringsertralineandclozapinelevels AT goncalvescerejeiraj monitoringsertralineandclozapinelevels AT gonzagaa monitoringsertralineandclozapinelevels |